The kinase Mirk/dyrk1B: A possible therapeutic target in pancreatic cancer

Cancers

Volumn 2, Issue 3, 2010, Pages 1492-1512

  Friedman, Eileen ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Dyrk; K ras; Mirk; Reactive oxygen species (ROS)

Indexed keywords

K RAS PROTEIN; PROTEIN MIRK; PROTEIN SERINE THREONINE KINASE; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

CANCER CELL; CELL CYCLE G0 PHASE; CELL SURVIVAL; CELL VIABILITY; COLONY FORMATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; GENE; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; HUMAN; MIRK GENE; NONHUMAN; PANCREAS CANCER; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN TARGETING; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 79952264076     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers2031492     Document Type: Review

References (36)

1. Stanton, K.J.; Sidner, R.A.; Miller, G.A.; Cummings, O.W.; Schmidt, C.M.; Howard, T.J.; Wiebke, E.A. Analysis of Ki-67 antigen expression, DNA proliferative fraction, and survival in resected cancer of the pancreas. Am. J. Surg. 2003, 186, 486-492.
2. Tejedor, F.; Zhu, X.; Kaltenbach, E.; Ackermann, A.; Baumann, A.; Canal, I.; Heisenberg, M.; Fischbach, K.; Pongs, O. Minibrain:a new protein kinase family involved in postembryonic neurogenesis in Drosophila. Neuron 1995, 14, 287-301.
3. Kentrup, H.; Becker, W.; Heukelbach, J.; Wilmes, A.; Schurman, A.; Huppertz, C.; Kainulainen, H.; Joost, H.-G. Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII. J. Biol. Chem. 1996, 271, 3488-3495.
4. Becker, W.; Weber, Y.; Wetzel, K.; Eirmbter, K.; Tejedor, F.; Joost, H.G. Sequence characteristics, subcellular localization and substrate specificity of dyrk-related kinases, a novel family of dual specificity protein kinases. J. Biol. Chem. 1998, 273, 25893-25902.
5. Mercer, S.E.; Ewton, D.Z.; Deng, X.; Lim, S.; Mazur, T.R.; Friedman, E. Mirk/Dyrk1B Mediates Survival during the Differentiation of C2C12 Myoblasts. J. Biol. Chem. 2005, 280, 25788-25801.
6. Arron, J.R.; Winslow, M.M.; Polleri, A.; Chang, C.P.; Wu, H.; Gao, X.; Neilson, J.R.; Chen, L.; Heit, J.J.; Kim, S.K.; Yamasaki, N.; Miyakawa, T.; Francke, U.; Graef, I.A.; Crabtree, G.R. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 2006, 441, 595-600.
7. Geiger, J.N.; Knudsen, G.T.; Panek, L.; Pandit, A.K.; Yoder, M.D.; Lord, K.A.; Creasy, C.L.; Burns, B.; Gaines, P.; Dillon, S.B.; Wojchowski, D.M. mDYRK3 kinase is expressed selectively in late erythroid progenitor cells and attenuates colony-forming unit-erythroid development. Blood 2001, 97, 901-910.
8. Li, K.; Zhao, S.; Karur, V.; Wojchowski, D.M. DYRK3 Activation, Engagement of Protein Kinase A/cAMP Response Element-binding Protein, and Modulation of Progenitor Cell Survival. J. Biol. Chem. 2002, 277, 47052-47060.
9. Sacher, F.; Moller, C.; Bone, W.; Gottwald, U.; Fritsch, M. The expression of the testis-specific Dyrk4 kinase is highly restricted to step 8 spermatids but is not required for male fertility in mice. Mol. Cell. Endocrinol. 2007, 267, 80-88.
10. Leder, S.; Czajkowska, H.; Maenz, B.; de Graaf, K.; Barthel, A.; Joost, H.G.; Becker, W. Alternative splicing variants of the protein kinase DYRK1B exhibit distinct patterns of expression and functional properties. Biochem. J. 2003, 372, 881-888.
11. Jin, K.; Park, S.J.; Ewton, D.; Friedman, E. The survival kinase Mirk/dyrk1B is a downstream effector of oncogenic K-ras. Cancer Res. 2007, 67, 7247-7255.
12. Deng, X.; Ewton, D.Z.; Li, S.; Naqvi, A.; Mercer, S.E.; Landas, S.; Friedman, E. The Kinase Mirk/Dyrk1B Mediates Cell Survival in Pancreatic Ductal Adenocarcinoma. Cancer Res. 2006, 66, 4149-4158.
13. Lee, K.; Deng, X.; Friedman, E. Mirk Protein Kinase Is a Mitogen-activated Protein Kinase Substrate That Mediates Survival of Colon Cancer Cells. Cancer Res 2000, 60, 3631-3637.
14. Karhu, R.; Mahlamaki, E.; Kallioniemi, A. Pancreatic adenocarcinoma- genetic portrait from chromosomes to microarrays. Genes Chromosomes Cancer 2006, 45, 721-730.
15. Moniaux, N.; Nemos, C.; Schmied, B.M.; Chauhan, S.C.; Deb, S.; Morikane, K.; Choudhury, A.; VanLith, M.; Sutherlin, M.; Sikela, J.M.; Hollingsworth, M.A.; Batra, S.K. The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis. Oncogene 2006, 25, 3247.
16. Kuuselo, R.; Savinainen, K.; Azorsa, D.O.; Basu, G.D.; Karhu, R.; Tuzmen, S.; Mousses, S.; Kallioniemi, A. Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification. Cancer Res. 2007, 67, 1943-1949.
17. Hruban, R.; Iacobuzio-Donahue, C.; Wilentz, R.; Goggins, M.; Kern, S. Molecular pathology of pancreatic cancer. Cancer J. 2001, 7, 251-258.
18. Tuveson, D.A.; Shaw, A.; Willis, N.; Silver, D.; Jackson, E.; Chang, S.; Mercer, K.; Grochow, R.; Hock, H.; Crowley, D.; Hingorani, S.; Zaks, T.; King, C.; Jacobetz, M.; Wang, L.; Bronson, R.; Orkin, S.; DePinho, R.; Jacks, T.E. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 2004, 5, 375-387.
19. Lim, S.; Jin, K.; Friedman, E. Mirk Protein Kinase Is Activated by MKK3 and Functions as a Transcriptional Activator of HNF1alpha. J. Biol. Chem. 2002, 277, 25040-25046.
20. Lim, S.; Zou, Y.; Friedman, E. The Transcriptional Activator Mirk/Dyrk1B Is Sequestered by p38alpha /beta MAP Kinase. J. Biol. Chem. 2002, 277, 49438-49445.
21. Jin, K.; Lim, S.; Mercer, S.E.; Friedman, E. The Survival Kinase Mirk/dyrk1B Is Activated through Rac1-MKK3 Signaling. J. Biol. Chem. 2005, 280, 42097-42105.
22. Deng, X.; Ewton, D.Z.; Mercer, S.E.; Friedman, E. Mirk/dyrk1B Decreases the Nuclear Accumulation of Class II Histone Deacetylases during Skeletal Muscle Differentiation. J. Biol. Chem. 2005, 280, 4894-4905.
23. Deng, X.; Ewton, D.Z.; Pawlikowski, B.; Maimone, M.; Friedman, E. Mirk/dyrk1B Is a Rhoinduced Kinase Active in Skeletal Muscle Differentiation. J. Biol. Chem. 2003, 278, 41347-41354.
24. Deng, X.; Mercer, S.E.; Shah, S.; Ewton, D.Z.; Friedman, E. The Cyclin-dependent Kinase Inhibitor p27Kip1 Is Stabilized in G0 by Mirk/dyrk1B Kinase. J. Biol. Chem. 2004, 279, 22498-22504.
25. Lambert, J.M.; Lambert, Q.T.; Reuther, G.W.; Malliri, A.; Siderovski, D.P.; Sondek, J.; Collard, J.G.; Der, C.J. Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism. Nat. Cell Biol. 2002, 4, 621-625.
26. Baines, A.T.; Lim, K.; Shields, J.M.; Lambert, J.M.; Counter, C.M.; Der, C.J.; Cox, A.D.; Balch, W.; Der, C.; Hall, A. Use of Retrovirus Expression of Interfering RNA to Determine the Contribution of Activated K-Ras and Ras Effector Expression to Human Tumor Cell Growth. Methods Enzymol. 2006, 407, 556-574.
27. Deng, X.; Ewton, D.Z.; Friedman, E. Mirk/Dyrk1B maintains the viability of quiescent pancreatic cancer cells by decreasing ROS levels. Cancer Res. 2009, 69, 3317-3324.
28. Ewton, D.; Lee, K.; Deng, X.; Lim, S.; Friedman, E. Rapid turnover of cell-cycle regulators found in Mirk/dyrk1B transfectants. Int. J. Cancer 2003, 103, 21-28.
29. von Groote-Bidlingmaier, F.; Schmoll, D.; Orth, H.-M.; Joost, H.-G.; Becker, W.; Barthel, A. DYRK1 is a co-activator of FKHR (FOXO1a)-dependent glucose-6-phosphatase gene expression. Biochem. Biophys. Res. Commun. 2003, 300, 764-769.
30. Nemoto, S.; Finkel, T. Redox Regulation of Forkhead Proteins Through a p66shc-Dependent Signaling Pathway. Science 2002, 295, 2450-2452.
31. Pelicano, H.; Carney, D.; Huang, P. ROS stress in cancer cells and therapeutic implications. Drug Resist. Updat. 2004, 7, 97-110.
32. Trachootham, D.; Zhou, Y.; Zhang, H.; Demizu, Y.; Chen, Z.; Pelicano, H.; Chiao, P.; Achanta, G.; Arlinghaus, R.; Liu, J.; Huang, P. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by ß-phenylethyl isothiocyanate. Cancer Cell 2006, 10, 241-252.
33. Bielas, J.H.; Heddle, J.A. From the Cover: Proliferation is necessary for both repair and mutation in transgenic mouse cells. Proc. Natl. Acad. Sci. USA 2000, 97, 11391-11396.
34. Bielas, J.H.; Heddle, J.A. Quiescent murine cell lack global genomic repair but are proficient in transcription-coupled repair. DNA Repair 2004, 3, 711-717.
35. Shen, M.; Yen, A. c-Cbl Interacts with CD38 and Promotes Retinoic Acid-Induced Differentiation and G0 Arrest of Human Myeloblastic Leukemia Cells. Cancer Res. 2008, 68, 8761-8769.
36. Chen, C.; Liu, Y.; Liu, R.; Ikenoue, T.; Guan, K.L.; Liu, Y.; Zheng, P. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J. Exp. Med. 2008, 205, 2397-2408.